
UI Investissement is an independent French private equity firm founded in 1967 and headquartered in Paris. It invests in unlisted SMEs and mid-cap companies (ETIs) across France, providing capital for development, transmission (LBO), innovation, and consolidation across sectors including healthcare, agribusiness, industry, and services.
Deal activity decreased year-over-year (2 deals in the last 12 months vs 6 prior). Average disclosed round size is $28.0M (across 5 rounds with reported amounts).
Portfolio
54
Fund Size
—
Top Stage
Unknown
Last 12 Mo
2
Team
Alexis Valles
Comptable
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
65 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | Dec 2025 | |
| Series A | — | Oct 2025 | |
| DDillico | Seed | — | Jul 2025 |
| FFungu'it | Unknown | — | Jun 2025 |
| Series C | — | Apr 2025 | |
| DDEEPULL DIAGNOSTICS, S.L. | Series C | — | Apr 2025 |
| Series A | $33M | Jan 2025 | |
| Unknown | — | Jan 2025 | |
| Series A | — | Jan 2025 | |
| Series A | $32M | Jan 2025 | |
| Series B | — | Nov 2024 | |
| OOverseed Biotech | Series A | — | Jul 2024 |
| Series B | $30M | Jan 2024 | |
| Series B | $30M | Jan 2024 | |
| Series C | — | Jan 2024 | |
| BBrenus Pharma | Series A | — | Jan 2024 |
| Unknown | — | Jan 2024 | |
| UUltrawatt | Seed | — | Jan 2024 |
| Series A | — | Oct 2023 | |
| Series A | — | Jul 2023 | |
| NNextbiotix | Series A | — | Jul 2023 |
| EExeliom Biosciences | Series A | — | Jul 2023 |
| Seed | — | Jan 2023 | |
| OOrikio | Series A | — | Jan 2023 |
| Series A | — | Jan 2023 |
Page 1 of 3
Top Co-Investors
Bpifrance16 shared
Angelor6 shared
Kurma Partners5 shared
Blast.Club5 shared
Innovacom5 shared
Elaia4 shared
Evolem3 shared
Crescent Capital Group3 shared
Biocodex3 shared
Capital Grand Est3 shared
CE Ventures3 shared
Omnes Capital3 shared
Kima Ventures3 shared
Asabys Partners3 shared
EIT InnoEnergy2 shared
Turenne Capital2 shared
Seroba Life Sciences2 shared
Idinvest2 shared
Fund+2 shared
Last updated: 20 October 2026